- Report
- August 2025
- 192 Pages
Global
From €3450EUR$3,939USD£2,994GBP
Delavirdine is an antiretroviral drug used in the treatment of HIV/AIDS. It is a non-nucleoside reverse transcriptase inhibitor (NNRTI) that works by blocking the action of the enzyme reverse transcriptase, which is essential for the virus to replicate. Delavirdine is used in combination with other antiretroviral drugs to treat HIV infection. It is usually prescribed to patients who have developed resistance to other NNRTIs. Delavirdine is available in tablet form and is taken orally.
Delavirdine is an important part of the HIV/AIDS treatment landscape. It is used to treat patients who have developed resistance to other NNRTIs, and it is an important part of combination therapy for HIV/AIDS. Delavirdine is generally well tolerated, with few side effects.
Some companies in the Delavirdine market include Bristol-Myers Squibb, GlaxoSmithKline, Merck, and Pfizer. Show Less Read more